Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommaso De Pas

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Med (New York, N.Y.)|June 14, 2025
Point of view: Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumorsFabio Conforti, Tommaso De Pas
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2010
Differences of gene expression in non-small cell lung cancer: are histology, tumor site, and methodology relevant?Francesca Toffalorio, Tommaso De Pas, Elisa Giovannetti
Seminars in Oncology|October 3, 2022
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to actionLaura Pala, Tommaso De Pas, Fabio Conforti
Cancer Cell|May 10, 2022
Boosting anticancer immunotherapy through androgen receptor blockadeLaura Pala, Tommaso De Pas, Fabio Conforti
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making processTommaso De Pas, Filippo de Braud, Giulia Veronesi
Future Oncology (London, England)|September 12, 2017
Molecular and clinical features of second-generation anaplastic lymphoma kinase inhibitors: ceritinibTommaso De Pas, Laura Pala, Chiara Catania, et al.
Cancer Treatment Reviews|April 10, 2020
Thymic epithelial tumors: From biology to treatmentFabio Conforti, Laura Pala, Giuseppe Giaccone, et al.
Pharmacogenomics|July 31, 2012
Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?Elisa Giovannetti, Francesca Toffalorio, Tommaso De Pas, et al.
The Lancet. Oncology|December 11, 2002
Endometrial malignant melanoma rediagnosed as clear-cell "sugar" tumourCarlos Miró, Hugo Marsiglia, Hossein Mousavinasab, et al.
Expert Opinion on Investigational Drugs|August 12, 2022
Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trialsFabio Conforti, Laura Pala, Tommaso De Pas, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Med (New York, N.Y.)|June 14, 2025
Point of view: Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumorsFabio Conforti, Tommaso De Pas
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2010
Differences of gene expression in non-small cell lung cancer: are histology, tumor site, and methodology relevant?Francesca Toffalorio, Tommaso De Pas, Elisa Giovannetti
Seminars in Oncology|October 3, 2022
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to actionLaura Pala, Tommaso De Pas, Fabio Conforti
Cancer Cell|May 10, 2022
Boosting anticancer immunotherapy through androgen receptor blockadeLaura Pala, Tommaso De Pas, Fabio Conforti
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making processTommaso De Pas, Filippo de Braud, Giulia Veronesi
Future Oncology (London, England)|September 12, 2017
Molecular and clinical features of second-generation anaplastic lymphoma kinase inhibitors: ceritinibTommaso De Pas, Laura Pala, Chiara Catania, et al.
Cancer Treatment Reviews|April 10, 2020
Thymic epithelial tumors: From biology to treatmentFabio Conforti, Laura Pala, Giuseppe Giaccone, et al.
Pharmacogenomics|July 31, 2012
Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?Elisa Giovannetti, Francesca Toffalorio, Tommaso De Pas, et al.
The Lancet. Oncology|December 11, 2002
Endometrial malignant melanoma rediagnosed as clear-cell "sugar" tumourCarlos Miró, Hugo Marsiglia, Hossein Mousavinasab, et al.
Expert Opinion on Investigational Drugs|August 12, 2022
Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trialsFabio Conforti, Laura Pala, Tommaso De Pas, et al.
Pageof 13